Company:  ANACOR PHARMACEUTICALS, I ... (ANAC)
Form Type:  8-K
Filing Date:  4/8/2013 
CIK:  0001411158 
Address:  1020 E. MEADOW CIRCLE 
City, State, Zip:  PALO ALTO, California 94303 
Telephone:  650-543-7500 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$16.45  
Change: 
-0.38 (-2.26%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$688.25M
Description of Business
We are a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from our boron chemistry platform. We have demonstrated that our organization, utilizing our boron chemistry platform, is highly productive and efficient at creating novel clinical product candidates. We have discovered, synthesized and developed eight molecules that are currently in development, and we believe that our organization and boron chemistry platform have the potential to continue to yield clinical candidates at a relatively constant rate and efficiency in the future. While drug development is often uncertain and occasionally uneven, our current portfolio of product candidates and our ability to efficiently fill our own pipeline provide us with a unique opportunity to create a valuable and sustainable biopharmaceutical company.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 3 SECURITIES AND TRADING MARKETS
      ITEM 3.02 UNREGISTERED SALES OF EQUITY SECURITIES.
    SECTION 8 OTHER EVENTS
      ITEM 8.01 OTHER EVENTS.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
    SIGNATURES
    INDEX TO EXHIBITS
  EXHIBIT 4.1
  EXHIBIT 99.1
BROKERAGE PARTNERS